Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:QDEL - US2197981051 - Common Stock

33.2 USD
-2.18 (-6.16%)
Last: 1/16/2026, 8:00:01 PM
33.11 USD
-0.09 (-0.27%)
After Hours: 1/16/2026, 8:00:01 PM
Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QDEL have multiple concerns. QDEL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • QDEL had positive earnings in the past year.
  • QDEL had a positive operating cash flow in the past year.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • QDEL had a positive operating cash flow in each of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

  • QDEL has a Return On Assets (-20.78%) which is in line with its industry peers.
  • QDEL's Return On Equity of -57.90% is in line compared to the rest of the industry. QDEL outperforms 47.57% of its industry peers.
  • The Return On Invested Capital of QDEL (1.74%) is better than 67.57% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for QDEL is below the industry average of 8.84%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.98%, QDEL is in the better half of the industry, outperforming 68.11% of the companies in the same industry.
  • QDEL's Operating Margin has declined in the last couple of years.
  • QDEL has a Gross Margin (47.15%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
  • Compared to 1 year ago, QDEL has more shares outstanding
  • QDEL has more shares outstanding than it did 5 years ago.
  • QDEL has a worse debt/assets ratio than last year.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.85, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.85, QDEL perfoms like the industry average, outperforming 49.19% of the companies in the same industry.
  • QDEL has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
  • QDEL has a worse Debt to Equity ratio (1.23) than 77.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.17
WACC10.11%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.78, QDEL is doing worse than 67.03% of the companies in the same industry.
  • A Quick Ratio of 0.98 indicates that QDEL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, QDEL is doing worse than 75.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

  • QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.18%.
  • Measured over the past years, QDEL shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.03% on average per year.
  • The Revenue has decreased by -3.67% in the past year.
  • The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%

3.2 Future

  • Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 21.56% on average per year.
  • The Revenue is expected to grow by 1.98% on average over the next years.
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.27%
Revenue Next 5Y1.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • QDEL is valuated correctly with a Price/Earnings ratio of 14.50.
  • Compared to the rest of the industry, the Price/Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 88.65% of the companies listed in the same industry.
  • QDEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.47.
  • Based on the Price/Forward Earnings ratio of 12.84, the valuation of QDEL can be described as correct.
  • QDEL's Price/Forward Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 90.81% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (24.26), we can say QDEL is valued slightly cheaper.
Industry RankSector Rank
PE 14.5
Fwd PE 12.84
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 93.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.08
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • QDEL's earnings are expected to grow with 21.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.98
PEG (5Y)N/A
EPS Next 2Y18.22%
EPS Next 3Y21.95%

0

5. Dividend

5.1 Amount

  • No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield 0%

QUIDELORTHO CORP

NASDAQ:QDEL (1/16/2026, 8:00:01 PM)

After market: 33.11 -0.09 (-0.27%)

33.2

-2.18 (-6.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-11
Inst Owners123.47%
Inst Owner Change-0.06%
Ins Owners0.61%
Ins Owner Change0.71%
Market Cap2.26B
Revenue(TTM)2.71B
Net Income(TTM)-1.18B
Analysts74.29
Price Target37.59 (13.22%)
Short Float %16.97%
Short Ratio8.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)0%
PT rev (3m)-10.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.76%
EPS NY rev (1m)-2.07%
EPS NY rev (3m)-11.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.31%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 14.5
Fwd PE 12.84
P/S 0.83
P/FCF N/A
P/OCF 60.46
P/B 1.11
P/tB N/A
EV/EBITDA 9.08
EPS(TTM)2.29
EY6.9%
EPS(NY)2.59
Fwd EY7.79%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY1.65%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.98
PEG (5Y)N/A
Graham Number39.3
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.85
F-Score5
WACC10.11%
ROIC/WACC0.17
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.27%
Revenue Next 5Y1.98%
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year938.62%
EBIT Next 3Y132.95%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 5 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 14.5 and the Price/Book (PB) ratio is 1.11.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 14.78% in the next year.